Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
proposal for classification and nomenclature by the Phonosurgery Committee <strong>of</strong> the <strong>European</strong><br />
Laryngological Society. Eur Arch Otorhinolaryngol 258:389-396<br />
89. Fröhlich G, Burmeister S, Wiedemann A, Bulitta M (1998) Intravesical instillation <strong>of</strong> trospium chloride,<br />
oxybutynin and verapamil for relaxation <strong>of</strong> the bladder detrusor muscle. A placebo<br />
controlled, randomized clinical test. Arzneimittelforschung 48:486-491<br />
90. Fromm GH, Terrence CF, Chattha AS (1984) Bacl<strong>of</strong>en in the treatment <strong>of</strong> trigeminal neuralgia:<br />
double-blind study and long-term follow-up. Ann Neurol 15:240-244<br />
91. Fünfstück R, Straube E, Schildbach O, Tietz U (1997) Prevention <strong>of</strong> reinfection by L-methionine in<br />
patients with recurrent urinary tract infection. Med Klin 92:574-581<br />
92. Furlan A, Brosseau L, Welch V, Wong J (2001) Massage for low back pain. Cochrane Database Syst<br />
Rev. 2002;(2):CD001929<br />
93. Gallien P, Reymann JM, Amarenco G, Nicolas B, de Sèze M, Bellissant E (2005) Placebo controlled,<br />
randomised, double blind study <strong>of</strong> the effects <strong>of</strong> botulinum A toxin on detrusor sphincter dyssynergia<br />
in multiple sclerosis patients. J Neurol Neurosurg Psychiat 76: 1670-1676<br />
94. Gangji V, Appelboom T (1999) Analgesic effect <strong>of</strong> intravenous pamidronate on chronic back pain<br />
due to osteoporotic vertebral fractures. Clin Rheumatol 18:266-267<br />
95. Gbadamosi J, Buhmann C, Moench A, Heesen C (2001) Failure <strong>of</strong> ondansetron in treating cerebellar<br />
tremor in <strong>MS</strong> patients—an open-label pilot study. Acta Neurol Scand 104:308-311<br />
96. Geisler MW, Sliwinski M, Coyle PK (1996) The effects <strong>of</strong> amantadine and pemoline on cognitive<br />
functioning in <strong>MS</strong>. Arch Neurol 53:185-188<br />
97. Giannantoni A, Scivoletto G, Di Stasi SM, Silecchia A, Finazzi-Agro E, Micali I, Castellano V (1998) Clean<br />
intermittent catheterization and prevention <strong>of</strong> renal disease in spinal cord injury patients. Spinal<br />
Cord 36:29-32<br />
98. Giannantoni A, Di Stasi SM, Stephen RL, Navarra P, Scivoletto G, Mearini E, Porena M (2002) Intravesical<br />
capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized<br />
study. J Urol 167:1710-1714<br />
99. Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, Reiners C, Toyka KV (2000) Injections <strong>of</strong><br />
botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J<br />
Neurol Neurosurg Psych; 69:121 – 123<br />
100. Gil D, Hatcher S (2003) Antidepressants for depression in medical illness. Cochrane Database Syst<br />
Rev. 2000;(4):CD001312<br />
101. Glasauer S, Kalla R, Büttner U, Strupp M, Brandt T (2005) 4-aminopyridine restores visual ocular<br />
motor function in upbeat nystagmus JNNP 76:451-453<br />
102. Glennen S, DeCoste D (1997) Handbook <strong>of</strong> augmentation and alternative communication. San<br />
Diego: Singular Publishing<br />
47 E<strong>MS</strong>P, <strong>Symptomatic</strong> <strong>Treatment</strong> <strong>of</strong> <strong>Multiple</strong> <strong>Sclerosis</strong>, December 2006 - revised in April 2008
Change language